Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Psyvox 750mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Psychocare Health Pvt Ltd

Salt Composition

Divalproex (750mg)

Overview Psyvox 750mg Tablet ER

Epileptin XR 750mg tablets are prescribed for epilepsy management, preventing and controlling seizures. They're also indicated in migraine prophylaxis and, in some cases, bipolar disorder. Epileptin XR 750mg may be administered alone or alongside other medications; dosage and frequency are determined by your physician to optimize symptom control. Take this medication at the same time daily, with or without food, for maximum effectiveness. Therapeutic effects typically manifest within a couple of weeks. Consistent use, as directed, is crucial; missed doses can trigger seizures, and abrupt cessation can worsen your condition. Gradual discontinuation under medical supervision is essential. Common side effects, often mild, include headache, blurred vision, nausea, vomiting, dizziness, fatigue, imbalance, easy bruising, and hypothermia. Consult your doctor if these persist or are bothersome. Report any skin rash or redness immediately. Prolonged use may result in osteoporosis and increased fracture risk. Rarely, suicidal ideation or behavior may occur; inform your doctor of any mood changes. Prior to commencing treatment, disclose any history of heart problems, kidney or liver disease, urinary difficulties, depression, or suicidal thoughts. Many medications can interact; provide a complete medication list to your doctor to ensure safety. Pregnant patients should consult their physician before initiating or discontinuing this medication. Alcohol consumption should be avoided due to potential side effect exacerbation and increased seizure risk. Regular blood tests, pre- and post-treatment, may be necessary for optimal dose monitoring.

Primary Ingredients of Psyvox 750mg Tablet ER

No information provided. A rephrased version cannot be created.

Uses of Psyvox 750mg Tablet ER

Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prophylaxis

Major Benefits of Psyvox 750mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the 750mg extended-release Psyvox tablet whole; avoid chewing, crushing, or fracturing. Consumption may coincide with or precede meals, though consistent timing is recommended.

Common Side effects of Psyvox 750mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Psyvox 750mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Psyvox 750mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.

How Psyvox 750mg Tablet ER works:

Extended-release Psyvox 750mg tablets are used to treat epilepsy. Their mechanism of action involves reducing overactive neuronal firing in the brain, thus managing seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Psyvox 750mg extended-release tablets and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Psyvox 750mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Psyvox 750mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no apparent risk to the infant.

DrivingDrivingUNSAFE

Extended-release Psyvox 750mg tablets may impair driving ability due to potential adverse reactions.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Psyvox 750mg tablets pose no safety concerns for patients with kidney impairment; no dosage modification is necessary.

LiverLiverUNSAFE

Extended-release Psyvox 750mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take Psyvox 750mg Tablet ER :

Should you forget a Psyvox 750mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Psyvox 750mg Tablet ER

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Actions Sodium channel-blocking antiepileptic drugs

FAQs on Psyvox 750mg Tablet ER

Always consult your doctor before discontinuing Psyvox 750mg Tablet ER. Withdrawal should be gradual, under medical supervision, to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors.
Psyvox 750mg Extended-Release tablets may be used to stabilize mood in individuals experiencing rapid mood swings. The medication achieves this by reducing excessive brain activity associated with these fluctuations.
Yes, Psyvox 750mg Extended-Release tablets can lead to weight gain, possibly from increased appetite. Manage your diet and exercise to minimize this risk. Consult your doctor about any weight concerns.
Drowsiness is a possible side effect of Psyvox 750mg Tablet ER. Refrain from driving or activities demanding concentration until you understand its impact on you.
Hair loss is a possible, temporary side effect of Psyvox 750mg ER tablets, often linked to dosage. Consult your doctor if this occurs or continues.
Liver damage is a potential side effect of Psyvox 750mg Tablet ER, particularly within the first six months of treatment. Symptoms such as nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes) may indicate liver problems. Baseline liver function tests are recommended before starting treatment, with regular monitoring during the initial six months, especially for at-risk individuals or those with pre-existing liver conditions.
Refrain from alcohol while taking Psyvox 750mg ER tablets. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Prior to commencing treatment with Psyvox 750mg Tablet ER, your doctor may order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation studies to help prevent spontaneous bleeding or bruising. Liver function tests are also recommended before and, for high-risk patients or those with pre-existing liver conditions, periodically during the first six months of treatment.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result requires immediate medication cessation.
Taking too much Psyvox 750mg Extended-Release tablet can lead to headaches, blurry vision (from constricted pupils), reduced reflexes, confusion, and drowsiness. You might also experience muscle weakness, seizures, unconsciousness, altered behavior, and breathing problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Psyvox 750mg Tablet ER
112
MRP 130
13% off